Texas

Have you ever asked your doctor whether the drug they are prescribing you is FDA-approved for how they are prescribing it? When a doctor prescribes an FDA-approved drug for a disease or condition, age group, or dosage other than what it has been approved for, then it is called an unapproved, or “off-label,” use.

Biotech and pharma companies tap new members of executive leadership teams and boards.

According to the poll results, 78% of respondents agree that the high costs of a gene therapy treatment are worth it, due to the fact that these options are seen as potential cures for disease.

Last week there were quite a few clinical trials whose data were presented. Many were at the American Diabetes Association 79th Scientific Sessions, while others were presented at separate meetings or independently. Here’s a look.

Biotech and pharma companies strengthen their leadership teams and boards with new hires and appointments.

Texas-based Savara tried to put a positive spin on the trial and pointed to positive secondary endpoints but it wasn’t enough to please investors.

Here’s a look at some of last week’s clinical trial announcements, including some from the American Society of Clinical Oncology Annual Meeting you might have missed.

Here are some of the top research stories that happened around the industry this week.

The funding will be used to advance clinical development of its lead asset, a treatment for loculated pleural effusions, which is a serious complication of pneumonia.

As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your if you have ‘work-life balance’ with your job.